Enoxaparin sodium, sold under the brand name Lovenox among others, is an anticoagulant medication (blood thinner).[11] It is used to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE) including during pregnancy and following certain types of surgery.[11] It is also used in those with acute coronary syndrome (ACS) and heart attacks.[11] It is given by injection just under the skin or into a vein.[11] It is also used during hemodialysis.[8][10]
Common side effects include bleeding, fever, and swelling of the legs.[11] Bleeding may be serious especially in those who are undergoing a spinal tap.[11] Use during pregnancy appears to be safe for the baby.[11] Enoxaparin is in the low molecular weight heparin family of medications.[11]
Enoxaparin was first made in 1981 and approved for medical use in 1993.[12][11] It is on the World Health Organization's List of Essential Medicines.[13] Enoxaparin is sold under several brand names and is available as a generic medication.[11] Enoxaparin is made from heparin.[12] In 2020, it was the 350th most commonly prescribed medication in the United States, with more than 500thousand prescriptions.[14]
^ ab"Summary Basis of Decision (SBD) for Axberi/Axberi HP". Health Canada. 26 January 2024. Archived from the original on 24 February 2024. Retrieved 24 February 2024.
^ abcdhttps://www.tga.gov.au/resources/auspmd/exaraneexarane-forte Archived 2 January 2024 at the Wayback Machine [bare URL]
^ abc"Enoxapo Australian prescription medicine decision summary". Therapeutic Goods Administration (TGA). 28 February 2020. Archived from the original on 26 February 2020. Retrieved 17 August 2020.
^"Enoxaparin Use During Pregnancy". Drugs.com. 15 July 2019. Archived from the original on 27 October 2020. Retrieved 16 August 2020.
^"FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 October 2023.
^"AusPAR: Exarane/Exarane Forte". Therapeutic Goods Administration (TGA). 4 March 2024. Retrieved 31 March 2024.
^"Summary Basis of Decision - Elonox/Elonox HP". Health Canada. 28 March 2023. Archived from the original on 25 April 2023. Retrieved 24 April 2023.
^ ab"Clexane Forte Syringes - Summary of Product Characteristics (SmPC)". emc. Archived from the original on 26 September 2018. Retrieved 12 October 2020.
^"Lovenox- enoxaparin sodium injection". DailyMed. U.S. National Library of Medicine. 28 April 2020. Archived from the original on 4 August 2020. Retrieved 16 August 2020.
^ abCite error: The named reference Inhixa EPAR was invoked but never defined (see the help page).
^ abcdefghij"Enoxaparin Sodium". The American Society of Health-System Pharmacists. Archived from the original on 21 December 2016. Retrieved 8 December 2016.
^ abNorthern Neonatal Network (2008). "Enoxaparin". Neonatal Formulary: Drug Use in Pregnancy and the First Year of Life. John Wiley & Sons. p. 96. ISBN 9780470750353. Archived from the original on 20 December 2016.
^World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
^"Enoxaparin - Drug Usage Statistics". ClinCalc. Archived from the original on 7 November 2022. Retrieved 7 October 2022.
Enoxaparinsodium, sold under the brand name Lovenox among others, is an anticoagulant medication (blood thinner). It is used to treat and prevent deep...
using comparability, for example, Omnitrope in May 2006, but this like Enoxaparin was also to a reference product, Genotropin, originally approved as a...
deep vein thrombosis and pulmonary embolism. Fondaparinux is similar to enoxaparin in reducing the risk of ischemic events at nine days, but it substantially...
ultra-LMWH because of its low molecular mass of 3600 g/mol on average. (Enoxaparin has 4500 g/mol.) These heparins have lower anti-thrombin activity than...
ultra-LMWH because of its low molecular mass of 2000–3000 g/mol on average. (Enoxaparin has 4500 g/mol) These heparins have lower anti-thrombin activity than...
venous catheters Heparin and its low-molecular-weight derivatives (e.g., enoxaparin, dalteparin, tinzaparin) are effective in preventing deep vein thromboses...
avoided in the first trimester, and a low-molecular-weight heparin such as enoxaparin is substituted. With heparin, risks of maternal haemorrhage and other...
yohimbine, atropine, orciprenaline, metoclopramide, ranitidine, metoprolol, enoxaparin, flucloxacillin, insulin, and irrigation of both eyes with saline. The...
A common low molecular weight heparin drug is called enoxaparin (brand name Lovenox). Enoxaparin is listed as Pregnancy Category B, meaning animal studies...
Manabe H, Schretter C, Clarke R, Cai Y, et al. (October 2014). "Trans-sodium crocetinate improves outcomes in rodent models of occlusive and hemorrhagic...